The Src family of non-receptor tyrosine kinases has been implicated in the regulation of cellular growth, dierentiation, migration, and survival. The Src-related protein Laloo was ®rst isolated in a screen for factors that alter axis formation during the early development of the frog, Xenopus laevis. Ectopic expression of Laloo generates tail duplications and the loss of anterior structures in Xenopus embryos, while inhibition of Src kinase activity blocks formation of the trunk and tail, indicating that these proteins are required for proper axis formation, in vivo (Weinstein et al., 1998) .
The complex phenotypic eects of Laloo overexpression and inhibition are likely the result of both primary and subsequent signaling events. The large size and rapid development of Xenopus embryos make them ideally suited for tissue explantation studies; such experiments allow for the analysis of gene function in a simpler context than that of the intact embryo. Both Laloo and the related Xenopus Fyn (Xfyn) induce ventrolateral mesoderm in isolated ectodermal explants (Steele et al., 1990; Weinstein et al., 1998; Weinstein and Hemmati-Brivanlou, 2001) . Mesoderm induction by these factors is blocked by reagents that inhibit signaling downstream of the Fibroblast Growth Factor (FGF) receptor, and Src family kinase activity is required for mesoderm induction by FGF (Weinstein et al., 1998; Weinstein and Hemmati-Brivanlou, 2001 ). Taken together, these epistatic studies strongly suggest that the Src kinases function as necessary components of the signaling cascade triggered by the FGF receptor during vertebrate development. The characterization of Laloo oered the ®rst de®nitive role for the intensely scrutinized Src gene family in early development, and provides one of the most dramatic examples of an in vivo requirement for the Src-related proteins in any context; the molecular interactions underlying this requirement, however, are not well de®ned.
The Src family kinases are regulated through phosphorylation and dephosphorylation of a conserved tyrosine residue close to the C-terminus (Brown and Cooper, 1996) . Phosphorylation at this site dramatically downregulates Src activity, and is catalyzed by members of the C-terminal Src Kinase (Csk) family, Csk and Chk (Brown and Cooper, 1996) ; the equivalent tyrosine in Laloo corresponds to residue 492 (Y492; Weinstein et al., 1998) . A functional Src/ Csk circuit has recently been reported in the primitive metazoan Hydra, suggesting that this signaling module is a fundamental feature of multicellular organisms (Miller et al., 2000) . Disruption of the csk gene in mice leads to mesodermal and neural tube defects, demonstrating an important role for this kinase in the regulation of early development (Imamoto and Soriano, 1993; Nada et al., 1993) . Although csk null mice display hyper-activation of several Src kinases, it is not clear how this activity leads directly to the observed abnormalities.
In Xenopus, mutation of Laloo-Y492 to phenylalanine (Y492F) generates a more potent mesoderm inducer than wild-type Laloo; furthermore, Y492F activity, unlike that of Laloo, is independent of basal signaling through the FGF receptor (Weinstein et al., 1998) . This suggests that the FGF receptor and Laloo are linked through the regulation of a kinase and/or phosphatase acting on Laloo Y492. Data from other systems suggest that Csk is a likely mediator of Laloo activity during mesoderm formation; we report here the functional characterization of Xenopus Csk (Xcsk).
A database search identi®ed a Xenopus cDNA with 84% identity to rat csk (Figure 1a ; Nada et al., 1991) . This Xenopus clone is most closely related to the vertebrate Csk genes, and shares signi®cantly less homology with the vertebrate csk-homologous kinase (chk) genes, indicating that it is the likely Xenopus homolog of csk. Like other members of this kinase family, Xcsk is a modular protein, containing a Src homology 3 (SH3) domain, involved in binding proline-rich sequences, a phosphotyrosine-binding Src homology 2 (SH2) domain, and a catalytic tyrosine kinase ( Figure 1a) .
In order to determine the temporal range of Xcsk expression during early development, we performed reverse transcription polymerase chain reaction (RT ± PCR) on RNA from early embryos ( Figure 1b) . Xcsk is expressed maternally, as transcripts are clearly present prior to the initiation of zygotic transcription at stage 8.5. This early phase of Xcsk expression is greatly diminished by midgastrula stages (stage 11.5). Xcsk is again detected at late neurula/early tailbud stages (stage 25) and is maintained until tadpole stages (stage 35). Curiously, the biphasic expression pattern of Xcsk closely parallels that observed for laloo, suggesting that the two genes may be regulated in a similar manner (Figure 1b, Weinstein et al., 1998) . It should be noted, however, that these studies do not directly address the RT ± PCR analysis of Xcsk and laloo expression during development. RT ± PCR was performed as described (Wilson and Hemmati-Brivanlou, 1995; Weinstein et al., 1998) . The`-RT' lane contains all reagents except reverse transcriptase and was used as a negative control. Xcsk primers are as follows: forward, 5'-GTGGTACCAAAGGTGGAG; reverse, 5'-GTAGTGACAGAGGAACCC. Other primer sequences are as described (Weinstein et al., 1998) . Ornithine decarboxylase (ODC) is used as a loading control (Bassez et al., 1990) RT ± PCR analysis of animal caps dissected at late blastula stages and cultured until midgastrula stages. EF1-a is used as a loading control (Krieg et al., 1989) . 1 ng laloo, 250 pg Y492F, and 2 ng Xcsk RNA were injected, as listed. For this study, cDNAs were subcloned into a modi®ed pCS2 vector. RNA was synthesized in vitro in the presence of cap analog using the mMessage mMachine kit (Ambion). Microinjection, explant dissection and dissociation cultures were performed as described (Hemmati-Brivanlou and Melton, 1994; Wilson and Hemmati-Brivanlou, 1995) . (c) Co-immunoprecipitation of epitope-tagged Laloo and Xcsk. Five ng of Laloo-Flag and/or CskMyc tagged (Csk-MT) RNA was injected into the animal poles of early cleavage stage embryos. Laloo-Flag includes the sequence DYKDDDDK at the Laloo C-terminus; CSK-MT contains six tandem repeats of the sequence MEQKLISEEDLNE at the Xcsk N-terminus. Embryos were lysed at stage 8 in 500 ul MW Lysis Buer (25 mM Tris pH 7.5, 0.1 M NaCl, 0.5% Triton X-100), and centrifuged twice at 14 000 K; following each centrifugation, only the clear lysate was retained. Lysates were incubated overnight at 48C with 1 : 500 antibody (Anti-¯ag M2 monoclonal or Monoclonal anti-C-myc clone 9E10 (Sigma)), followed by incubation with Protein A/G-PLUS-Agarose (Santa Cruz Biotechnology) for 1 h at 48C. After four washes in MW Lysis Buer, protein was eluted in 0.1 M Glycine, pH 3.5, neutralized with wash buer (0.05 M Tris, pH 7.4, 0.15 M NaCl), and subjected to standard SDS ± PAGE and Western blotting protocols We next assayed whether Xcsk could inhibit Src kinase activity in an ectodermal explant (animal cap) assay. Animal caps derived from laloo-injected embryos express both the panmesodermal marker Xbrachyury (Xbra) and the ventrolateral mesodermal marker Xwnt8 (Figure 2a , lane 1; Smith and Harland, 1991; Christian et al., 1991; Weinstein et al., 1998) . These explants do not express the dorsal mesodermal marker chordin (Sasai et al., 1994) . Mesodermal marker expression is not detected in animal caps from either untreated embryos ( Figure  2a, lane 4) , or from embryos injected with Xcsk ( Figure 2a, lane 2) . Co-expression of Xcsk completely blocks mesoderm induction by laloo (Figure 2a, lane  3) . These data indicate that Xcsk can function as an inhibitor of Src kinase function during mesoderm formation.
In mammalian cell culture assays, Csk has been shown to inhibit Src function through phosphorylation of a tyrosine residue at the C-terminus of the Src protein (Brown and Cooper, 1996) . To address whether the regulation of Laloo by Xcsk occurs by the same mechanism, we tested the eects of Xcsk RT ± PCR analysis of animal caps cultured until midgastrula stages. One ng or 100 pg (`low') laloo, 2 ng Xcsk, and 1 ng K222R were injected, as listed. (c) K222R synergizes with Laloo in the intact embryo. Lateral view of stage 37 embryos; anterior is to right. Top embryo was injected with 100 pg laloo RNA; bottom embryo was injected with 100 pg laloo and 1 ng K222R RNA. RNAs were injected into the animal pole regions of both embryos at early cleavage stages. Similar results were seen in 74% of embryos injected with both 100 pg laloo and 1 ng K222R RNA (n=19). This phenotype was not seen in uninjected embryos (n4100), or in embryos injected with only 100 pg laloo (n=30) or 1 ng K222R (n=30) RNA. (d) Detail of posterior of bottom embryo in (c), showing ectopic tails induced by co-expression of Laloo and K222R. K222R was generated by PCR: a point mutation (A?G) was introduced that resulted in a lysine (AAA) to arginine (AGA) mutation. The oligonucleotides used for this mutagenesis were as follows: K222R-U1: 5'-GTGAAAGTAGCTGTGAGATGTAT-CAAG. K222R-D1: 5'-GGCATCGTTCTTGATACATCTCACAGC on the activated Laloo mutant Y492F. As with wildtype laloo, Y492F RNA induces mesoderm in the animal cap assay ( Figure 2b , lane 3; Weinstein et al., 1998) ; this induction, however, is unaected by co-expression of Xcsk (Figure 2b, lane 4) . This result suggests that Xcsk inhibits Laloo activity via Y492 of Laloo.
Although Csk does not form a stable complex with all Src kinases, physical interaction between Csk and the Src-related Fyn protein has been reported (Takeuchi et al., 1993; Brown and Cooper, 1996) . As shown in Figure 2c , immunoprecipitation of epitopetagged Laloo will co-precipitate exogenous Xcsk. While this result does not prove that endogenous Laloo and Xcsk form a stable complex, it does suggest that these proteins may physically interact in vivo.
As described above, Csk inhibits Src kinase function via a phosphorylation event; thus, a kinase-inactive Csk mutant would be expected to lack activity. We constructed a kinase-defective Xcsk mutant, K222R, by disrupting the putative ATP phosphotransferase site (Chow et al., 1993; Honda et al., 1997) . As shown in Figure 3a , K222R expression does not block mesoderm induction by Laloo, indicating that Xcsk activity requires a functional kinase domain. The physical interaction between Laloo and Xcsk, described above, further suggested that K222R might function as a dominant-negative reagent, preventing the association of Laloo with wild-type Xcsk. To test this possibility, we assayed for synergy between K222R and subinducing levels of Laloo. Expression of either K222R or 100 pg laloo RNA (`laloo low') does not induce mesodermal marker gene expression (Figure 3b, lanes  1 and 2) . Co-expression of K222R and 100 pg laloo RNA, however, strongly induces the expression of both Xbrachyury and Xwnt8 (Figure 3b, lane 3) . This synergistic eect can be blocked by the additional expression of wild-type Xcsk (Figure 3b, lane 4) . These results demonstrate that K222R functions as a dominant-negative molecule, and suggests that endogenous Xcsk binds to and limits the activity of ectopic Laloo.
The eects of K222R expression on exogenous Laloo can also be observed in the context of the intact embryo. The embryo at the top of Figure 3c was injected with 100 pg laloo RNA; it is indistinguishable both from uninjected embryos and from embryos injected with up to 4 ng K222R RNA (data not shown). The embryo at the bottom of Figure 3c received both 100 pg laloo and K222R RNA. This embryo lacks anterior structures, including eyes and cement glands, and has formed two additional, rudimentary tails (Figure 3d ). This phenotype is similar to that seen following injection with high doses of laloo RNA (Weinstein et al., 1998 , and data not shown); thus, these experiments suggest that Xcsk plays a signi®cant role in modulating the eects of Src kinase activity during early Xenopus development.
We have recently postulated overlapping roles for Laloo and the related Xfyn kinase during mesoderm formation (Weinstein and Hemmati-Brivanlou, 2001 ). (Figure 4 , compare lanes 1 and 2). Furthermore, the Xcsk mutant K222R synergizes slightly with low doses of Xfyn (Figure 4, compare lanes 3 and 4) . It should be noted that Xfyn appears somewhat less sensitive than Laloo, both to inhibition by Xcsk and, particularly, to activation by K222R (Figure 4 and data not shown); the signi®cance of this dierence is not clear, at present.
Consistent with this possibility, mesoderm induction by Xfyn is inhibited by Xcsk
In this report, we demonstrate that Xcsk physically interacts with the Src kinase Laloo and blocks mesoderm induction by Laloo and Xfyn. More important, we show that the kinase-inactive Xcsk construct, K222R, synergizes with the Src kinases both in explant cultures and in the intact embryo. The most straightforward interpretation of these data is that K222R acts as a dominant-negative and competes with endogenous Xcsk or a related factor that binds and inhibits exogenous Xfyn or Laloo. This, in turn, suggests that, in vivo, Xcsk binds and inhibits Src family kinases during early embryogenesis. The lack of eect seen following K222R single injections, however, indicates that the activation of endogenous Laloo in the animal pole may require additional steps beyond a release from Xcsk inhibition.
In Xenopus laevis, mesoderm is induced in the marginal zone by signals emanating from the vegetal pole of the blastula-stage embryo. Although FGF has been proposed as a primary mesoderm-inducing signal, the expression patterns and activities of Xenopus FGFs are more consistent with an alternate model, whereby FGF pathway activation is responsible for the proper response to and maintenance of mesoderm induction (see LaBonne and Whitman, 1997; Curran and Grainger, Figure 4 Mesoderm induction by Xfyn is inhibited by Xcsk, and K222R synergizes with Xfyn. RT ± PCR analysis of animal caps cultured until midgastrula stages. One ng or 100 pg (`low') laloo, 1 ng or 100 pg (`low') Xfyn, 2 ng Xcsk, and 1 ng K222R were injected, as listed 2000). The ubiquitous early expression of Xcsk suggests that it may function as a general repressor of Src kinase activity throughout the early embryo, inhibiting ectopic, FGF-independent mesoderm induction by these factors. FGF-mediated activation of the Src kinases in the marginal zone could be achieved, then, either via inactivation of Xcsk, or by the activation of a competing phosphatase. Con®rmation of such a model will require the characterization of additional factors that function with the Src kinases during mesoderm formation. Alternatively, overexpression of Xcsk may mimic the eects of a related, tissue-restricted factor, whose action could also be blocked by K222R. Current studies include an attempt to identify additional members of the Csk gene family that are expressed during early Xenopus development.
